| HOME >> BIOLOGY >> TECHNOLOGY |
STAT3 and resistance to cisplatin 223
Biomarkers of radiation therapy for cancer 223
Role of biomarkers in drug development in oncology 223
Molecular imaging of tumor as a guide to drug development 224
Use of PET to assess response to anticancer drugs 225
Use of MRI to assess response to anticancer drugs 225
Biomarkers in plucked hair for assessing cancer therapy 225
Molecular targets of anticancer drugs as biomarkers 226
Safety biomarkers in oncology studies 226
Role of biomarkers in phase I clinical trials of anticancer drugs 226
Biomarkers according to location/type of cancer 227
Bladder cancer biomarkers 227
Detection of FGFR3 mutations in urine for diagnosis of bladder cancer 227
NMP22 BladderChek 227
Urinary telomerase as biomarker for detection of bladder cancer 228
Concluding remarks abut biomarkers of urinary cancer 228
Brain tumor biomarkers 228
14-3-3zeta positive expression as a prognostic biomarker for GBM 229
Biomarkers to predict response to EGFR inhibitors 229
CD133 as biomarker of resistance to radiotherapy 229
Circulating microvesicles as biomarkers 230
CSF protein profiling 230
CSF attractin as a biomarker of malignant astrocytoma 230
Methylation profiling of brain tumors 230
Metabolite biomarkers of brain tumors 231
miRNAs as biomarkers of brain tumors 232
MRI biomarker for response of brain tumor to therapy 232
Multigene predictor of outcome in GBM 232
Neuroimaging biomarkers combined with DNA microarray analysis 233
Receptor protein tyrosine phosphatase ? as biomarker of gliomas 233
Serum protein fingerprinting 233
VEGF-R2 as biomarker of angiogenesis in brain tumors 234
Bone tumor biomarkers 234
Cytogenetics for the study of bone and soft tissue tumors 234<
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |